Lutz Taubert

"Read it for no other reason than to learn Bob's Seven Immutable Laws of Business. . . . This is vintage Bob-contrarian, thoughtful, and he's really fun to read."—Forbes In this edition of Bob Lutz's bestselling account of the business philosophy with which he revolutionized Chrysler and much of the automotive industry, Lutz reveals his unique brand of creative management. Readers will learn many lessons herein, including why the key to success in any business is maintaining a positive tension between the creative minds and the buttoned-up financial minds, and how to attract, motivate, and strategically deploy each type throughout an organization. This book features a new introduction and an epilogue in which Lutz introduces an eighth law that helps today's business leaders put his famed Seven Immutable Laws of Business into sharper perspective. Robert A. Lutz (Scarsdale, NY) is General Motor's Vice Chairman of Product Development and Chairman of GM North America.

Edited by a leading authority in the field, the first book on this important and emerging topic provides an overview of the latest trends in sequence-controlled polymers. Following a brief introducti

The book provides an overview of the highly interdisciplinary field of surface science in the context of biological and biomedical applications. The covered topics range from micro- and nanostructurin

Radiation Oncology in Palliative Cancer Care represents the first dedicated attempt in book form to address the glaring absence of a well-written palliative radiation therapy reference and textbook th

This third volume of the Protein Engineering Handbook introduces recent advances in the development of novel, effective, and sustainable catalysts through enzyme engineering pioneered in the four year

Over recent years there have been major advances in the application of molecular, biotechnological and genetic techniques to a wide range of aquatic species. Until now, many working in a hands-on capa

Quantitative Molecular Pharmacology and Informatics in Drug Discovery Michael Lutz, Section Head, Cheminformatics Group and Terry Kenakin, Principal Research Scientist, Glaxo Wellcome Research and Dev

Behind the media headlines that chronicle the successes--as well as the charges of fraud, abuse, and ethical misconduct--of today's corporate medical giants lies the story of the Wall Street players w